Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers

Journal of Vascular Surgery

Volumn 38, Issue 6, 2003, Pages 1342-1348

  Senet, Patricia ^a,d,e   Bon, Franfçois Xavier ^a   Benbunan, Marc ^b   Bussel, Annette ^b   Traineau, Richard ^c   Calvo, Fabien ^d   Dubertret, Louis ^a   Dosquet, Christine ^b,f  

^a Institut de Recherche sur la Peau   (France)

^b Unite de Therapie Cellulaire   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HÔPITAL CHARLES FOIX   (France)

^f Unite de Therapie Cellulaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; PLACEBO; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BANDAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROCOLLOID; LEG COMPRESSION; LEG ULCER; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; ULCER HEALING; VENOUS BLOOD; WOUND HEALING;

EID: 0345167813     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00908-X     Document Type: Article

References (38)

1. Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and venous ulceration. J Am Acad Dermatol 2001;44:401-21.
2. Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V, & Venous Ulcer Study Group. Prognostic indicators in venous ulcers. J Am Acad Dermatol 2000;43:627-30.
3. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;314:738-46.
4. Harrison P, Cramer EM. Platelet α granules. Blood Rev 1993;7:52-62.
5. Brandt E, Ludwig A, Petersen F, Flad HD. Platelet-derived CXC chemokines: old players in new games. Immunol Rev 2000;177:204-16.
6. English D, Garcia JG, Brindley DN. Platelet-released phospholipids link hemostasis and angiogenesis. Cardiovasc Res 2001;49:588-99.
7. Snyder EL, Calhoun BC. Topical platelet growth factor therapy: of lotions and potions. Transfusion 2001;41:1186-9.
8. Demoyer JS, Skalak TC, Durieux ME. Lysophosphatidic acid enhances healing of acute cutaneous wounds in the mouse. Wound Rep Reg 2000;8:530-7.
9. McClain SA, Simon M, Jones E, Nandi A, Gailit JO, Tonnesen MG, et al. Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol 1996;149:1257-70.
10. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness, of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24:483-8.
11. Pâques M, Chastang C, Mathis A, Sahel J, Massin P, Dosquet C, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Ophthalmology 1999;106:932-8.
12. Zieren J. Castenholz E, Baumgart E, Muller JM. Effects of fibrin glue on growth factors released from platelets on abdominal hernia repair with resorbable PGA mesh: experimental study. J Surg Res 1999;85:267-72.
13. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA, Fylling CP. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care 1997;10:33-8.
14. Porter JM, Moneta GL, & International Consensus Committee on Chronic Venous Disease\?\. Reporting standards in venous disease: an update. J Vasc Surg 1995;21:635-45.
15. Kantor J, Margolis D. Efficacy and prognostic value of simple wound measurements. Arch Dermatol 1998;134:1571-4.
16. Gorin DR, Cordts PR, LaMorte WW, Menzoian JO. The influence of wound geometry on the measurement of wound healing rates in clinical trials. J Vasc Surg 1996;23:524-8.
17. Thawer HA, Houghton PE, Woodbury MG, Keast D, Campbell K. A comparison of computer-assisted and manual wound size measurement. Ostomy Wound Manage 2002;48:46-53.
18. Trengrove NJ, Stacey MC, Macauley S, Benet N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg 1999;7:442-52.
19. Stacey MC, Mata SD, Trengrove NJ, Mather CA. Randomized double-blind placebo controlled trial of autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 2000;20:296-301.
20. Knighton DR, Fiegel VD, Austin LL, Ciresi KF, Butler EL. Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet derived wound healing factors (PDWHF). Ann Surg 1986;204:322-30.
21. Gaudric A, Pâques M, Massin P, Santiago PY, Dosquet C. Use of autologous platelet concentrate in macular Hole Surgery: report of 77 cases. Dev Ophthalmol 1997;29:30-5.
22. Castelnovo L, Dosquet C, Gaudric A, Sahel J, Hicks D. Human platelet suspension stimulates porcine retinal glial proliferation and migration in vitro. Invest Ophthalmol Vis Sci 2000;41:601-9.
23. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001;41:1217-24.
24. Bornstein P. Thrombospondins as matricellular modulators of cell function J Clin Invest 2001;107:929-34.
25. Steed DL, Malone JM, Goslen JB, Bunt TJ, Holloway GA, Webster MW. Randomized prospective double-blind trial in healing chonic diabetic foot ulcers. Diabetes Care 1992;15:1598-1604.
26. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic non-healing wounds: a preliminary report. J Vasc Surg 1991;14:526-36.
27. Trengrove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokines levels in non-healing and healing leg ulcers. Wound Rep Reg 2000;8:13-25.
28. Loots MAM, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998;111:850-7.
29. Harris IR, Yee KC, Walters CE, Cunliffe WJ, Kearney JN, Wood EJ, et al. Cytokine and protease levels in healing and nonhealing chronic venous leg ulcers. Exp Dermatol 1995;4:342-9.
30. Cooper DM, Yu EZ, Hennessey P, Ko F, Robson MC. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994;219:688-92.
31. Drinkwater SL, Smith A, Sawyer BM, Burnand KG. Effect of venous ulcer exudates on angiogenesis in vitro. Br J Surg 2002;89:709-13.
32. 3-integrin expression in chronic wounds. Int J Mol Med 2000;6:515-9.
33. Mendez MV, Stanley A, Park HE, Shon K, Phillips T, Menzoian JO. Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 1998;28:876-83.
34. Agren MS, Steenfos HK, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999;112:463-9.
35. Stanley AC, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg 2001;33:1206-11.
36. Stanley AC, Park HY, Phillips TJ, Russakovsky V, Menzoian JO. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated by growth factors. J Vasc Surg 1997;26:994-1001.
37. Herouy Y, May AE, Pornschlegel G, Stetter C, Grenz H, Preissner KT, et al. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol 1998;111:822-7.
38. Seung JL. Cytokine delivery, and tissue engineering. Yonsei Med J 2000;41:704-19.